Literature DB >> 23161868

Ras-dva is a novel Pit-1- and glucocorticoid-regulated gene in the embryonic anterior pituitary gland.

Laura E Ellestad1, Tom E Porter.   

Abstract

Glucocorticoids play a role in functional differentiation of pituitary somatotrophs and lactotrophs during embryogenesis. Ras-dva was identified as a gene regulated by anterior neural fold protein-1/homeobox expressed in embryonic stem cells-1, a transcription factor known to be critical in pituitary development, and has an expression profile in the chicken embryonic pituitary gland that is consistent with in vivo regulation by glucocorticoids. The objective of this study was to characterize expression and regulation of ras-dva mRNA in the developing chicken anterior pituitary. Pituitary ras-dva mRNA levels increased during embryogenesis to a maximum on embryonic day (e) 18 and then decreased and remained low or undetectable after hatch. Ras-dva expression was highly enriched in the pituitary gland on e18 relative to other tissues examined. Glucocorticoid treatment of pituitary cells from mid- and late-stage embryos rapidly increased ras-dva mRNA, suggesting it may be a direct transcriptional target of glucocorticoids. A reporter construct driven by 4 kb of the chicken ras-dva 5'-flanking region, containing six putative pituitary-specific transcription factor-1 (Pit-1) binding sites and two potential glucocorticoid receptor (GR) binding sites, was highly activated in embryonic pituitary cells and up-regulated by corticosterone. Mutagenesis of the most proximal Pit-1 site decreased promoter activity in chicken e11 pituitary cells, indicating regulation of ras-dva by Pit-1. However, mutating putative GR binding sites did not substantially reduce induction of ras-dva promoter activity by corticosterone, suggesting additional DNA elements within the 5'-flanking region are responsible for glucocorticoid regulation. We have identified ras-dva as a glucocorticoid-regulated gene that is likely expressed in cells of the Pit-1 lineage within the developing anterior pituitary gland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23161868      PMCID: PMC3591683          DOI: 10.1210/en.2012-1566

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Signaling and transcriptional mechanisms in pituitary development.

Authors:  J S Dasen; M G Rosenfeld
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Identification of cis elements necessary for glucocorticoid induction of growth hormone gene expression in chicken embryonic pituitary cells.

Authors:  Kristina Heuck-Knubel; Monika Proszkowiec-Weglarz; Jyoti Narayana; Laura E Ellestad; Nattiya Prakobsaeng; Tom E Porter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-07       Impact factor: 3.619

3.  Ras-dva, a member of novel family of small GTPases, is required for the anterior ectoderm patterning in the Xenopus laevis embryo.

Authors:  Maria B Tereshina; Andrey G Zaraisky; Vladimir V Novoselov
Journal:  Development       Date:  2006-02       Impact factor: 6.868

4.  Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis.

Authors:  J S Dasen; J P Martinez Barbera; T S Herman; S O Connell; L Olson; B Ju; J Tollkuhn; S H Baek; D W Rose; M G Rosenfeld
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 5.  Regulation of pituitary somatotroph differentiation by hormones of peripheral endocrine glands.

Authors:  Tom E Porter
Journal:  Domest Anim Endocrinol       Date:  2005-07       Impact factor: 2.290

6.  Sequence and distribution of pro-opiomelanocortin in the pituitary and the brain of the chicken (Gallus gallus).

Authors:  H H Gerets; K Peeters; L Arckens; F Vandesande; L R Berghman
Journal:  J Comp Neurol       Date:  2000-02-07       Impact factor: 3.215

7.  Ontogeny of pituitary thyrotrophs and regulation by endogenous thyroid hormone feedback in the chick embryo.

Authors:  Michael Muchow; Ioannis Bossis; Tom E Porter
Journal:  J Endocrinol       Date:  2005-02       Impact factor: 4.286

8.  Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells.

Authors:  S Hentges; N Boyadjieva; D K Sarkar
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

9.  Embryonic development of the pituitary gland in the chick.

Authors:  Fumihiko Sasaki; Ayumi Doshita; Yoshiki Matsumoto; Sachi Kuwahara; Yasuhiro Tsukamoto; Kazushige Ogawa
Journal:  Cells Tissues Organs       Date:  2003       Impact factor: 2.481

10.  Differential abilities of chicken Pit1 isoforms to regulate the GH promoter: evidence for synergistic activation.

Authors:  Malini Mukherjee; Tom E Porter
Journal:  Endocrinology       Date:  2012-05-11       Impact factor: 4.736

View more
  4 in total

1.  Mechanisms involved in glucocorticoid induction of pituitary GH expression during embryonic development.

Authors:  Laura E Ellestad; Stefanie A Puckett; Tom E Porter
Journal:  Endocrinology       Date:  2015-01-05       Impact factor: 4.736

2.  Delayed access to feed alters expression of genes associated with carbohydrate and amino acid utilization in newly hatched broiler chicks.

Authors:  Jason A Payne; Monika Proszkowiec-Weglarz; Laura E Ellestad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-09       Impact factor: 3.619

3.  The Effect of Commercial Genetic Selection on Somatotropic Gene Expression in Broilers: A Potential Role for Insulin-Like Growth Factor Binding Proteins in Regulating Broiler Growth and Body Composition.

Authors:  Lauren A Vaccaro; Tom E Porter; Laura E Ellestad
Journal:  Front Physiol       Date:  2022-06-27       Impact factor: 4.755

Review 4.  From Pituitary Stem Cell Differentiation to Regenerative Medicine.

Authors:  Maria Andrea Camilletti; Julian Martinez Mayer; Sebastian A Vishnopolska; Maria Ines Perez-Millan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-19       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.